| Business Summary | | Optical
Sensors,
Inc.
is
engaged
in
developing,
manufacturing
and
marketing
fiberoptic
chemical
sensors
used
in
the
monitoring
of
key
physiologic
parameters
for
medically
unstable
patients.
Since
October
1998,
the
Company
has
been
focusing
its
resources
on
development
and
commercialization
of
the
CapnoProbe,
which
is
a
handheld
device
with
a
carbon
dioxide
(CO/2/)
probe
that
is
slipped
under
the
tongue
like
a
thermometer.
The
CapnoProbe
non-invasively
measures
the
tissue
CO/2/
of
the
mucous
membrane
in
the
mouth;
this
is
a
sensitive
measure
that
can
indicate
reduced
blood
flow
to
non-vital
organs.
In
December
2000,
the
Company
received
510(k)
clearance
from
the
FDA
to
market
the
CapnoProbe.
Since
January
1999,
the
Company
has
been
exploring
strategic
alternatives,
including
joint
ventures,
corporate
strategic
alliances,
sale
of
the
business
or
product
lines,
or
other
business
combinations. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | OPSI
is
a
development
stage
company
that
develops,
manufactures
and
markets
fiber
optic
chemical
sensors
for
blood
gas
monitoring
for
the
medically
unstable
patients
in
critical
and
intensive
care
units.
For
the
six
months
ended
6/30/01,
the
Company
reported
no
revenues.
Net
loss
fell
58%
to
$1.5
million.
Revenues
reflect
suspended
sales
and
support
activities.
Lower
loss
reflects
lower
interest
expenses
due
to
capitalized
leases
having
expired
in
2000. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| Paulita LaPlante, 43 Pres
and CEO | $180K | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|